Karger Publishers
Supplementary material-Supplementary_Table_1.docx (18.67 kB)

Supplementary Material for: Factors considered by experienced urologists when selecting alpha-blockers for patients with lower urinary tract symptoms or benign prostatic hyperplasia according to age

Download (18.67 kB)
posted on 2024-05-15, 08:54 authored by Lee H., Lee J.H., Choo M.S., Cho M.C., Son H., Jeong H., Yoo S.
Introduction: To examine the opinions of urology specialists on whether there are actual differences in efficacy among α1-blockers and to identify the factors that should be considered when prescribing these medications according to age. Methods: We surveyed 50 South Korean urology specialists with over 3 years of clinical experience in secondary or tertiary hospitals in July-August 2021. The survey covered urologists' demographics, awareness of α1-blocker prescription differences, and key factors in α1-blocker selection based on LUTS severity and patient age. Results: Overall, 82% of the respondents believed that there were differences in efficacy of α1-blockers in actual practice according to age. Over 90% of the respondents agreed on the need for head-to-head comparison studies to compare the effects of different α1-blockers. Regardless of the severity of LUTS, urologists prioritize cardiovascular side effects when prescribing α1-blockers to patients aged ≥70 years. Further, 19% of the urologists prioritized ejaculatory side effects for mild-to-moderate LUTS and 9% for severe LUTS (p < 0.001). Conclusions: This study shows that head-to-head studies comparing the efficacy of different α1-blockers are highly valuable for the real-world clinical application of α1-blockers. Notably, urologists prioritize cardiovascular and ejaculatory side effects in older and younger patients while prescribing α1-blockers, respectively.


Usage metrics

    Urologia Internationalis





    Ref. manager